P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,325.00
83.9 (1.34%)
BSENSE

Jun 18

BSE+NSE Vol: 10.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
0
663.66
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
0
663.66
Raw Material Cost
137.67
0
137.67
Purchase of Finished goods
34.95
0
34.95
(Increase) / Decrease In Stocks
-10.23
0
-10.23
Employee Cost
109.89
0
109.89
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
180.77
0.00
180.77
Total Expenditure (Excl Depreciation)
453.05
0
453.05
Operating Profit (PBDIT) excl Other Income
210.61
0.00
210.61
Other Income
8.98
0
8.98
Operating Profit (PBDIT)
219.59
0
219.59
Interest
0.24
0
0.24
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
219.35
0
219.35
Depreciation
11.52
0
11.52
Profit Before Tax
207.83
0
207.83
Tax
53.11
0
53.11
Provisions and contingencies
0.00
0
0.00
Profit After Tax
154.72
0
154.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
154.72
0
154.72
Equity Capital
16.60
0
16.60
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
93.20
0
93.20
Diluted Earnings per share
93.21
0
93.21
Operating Profit Margin (Excl OI)
31.73%
0%
0.00
31.73%
Gross Profit Margin
33.05%
0%
0.00
33.05%
PAT Margin
23.31%
0%
0.00
23.31%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024